Tissue Chip for Drug Screening
Owner/Developer: US National Institutes of Health, National Center for Advancing Transnational Research (NIH)
|Country:||United States of America|
The Tissue Chip for Drug Screening program aims to develop bioengineered devices to improve the process of predicting whether drugs will be safe or toxic in humans.
|Channel:||Social media - Website - Audio / Video|
|Audience:||Scientists - Researchers - Regulators - Industry|
|User access:||Open access|
|Updating frequency:||Last updated: 08-16-2016|
|Purpose:||Method development - Regulatory testing - Toxicological and safety evaluation - Efficacy testing - Documentation and information|
|Technology/Tools:||Alternative test methods (in vitro) - High throughput screening - Tissue engineering|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!Please contact us by email if you have any questions.